Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical ImagingROCO:6637 +1.64%86 Return-on-Tangible-Equity is 9.55% as of Mar. 2026, which is 59% below its 10-year median of 23.30. GuruFocus rates ROCO:6637 with a GF Score™ of 86/100 and a GF Value™ of NT$129.62 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 111 Medical Distribution companies, Medical Imaging ranks better than 72.07% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medical Imaging's annualized net income for the quarter that ended in Mar. 2026 was NT$108 Mil. Medical Imaging's average shareholder tangible equity for the quarter that ended in Mar. 2026 was NT$1,135 Mil. Therefore, Medical Imaging's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 9.55%.
The historical rank and industry rank for Medical Imaging's Return-on-Tangible-Equity or its related term are showing as below:
ROCO:6637'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 16.42 Med: 23.3 Max: 29.41
Current: 17.01
During the past 13 years, Medical Imaging's highest Return-on-Tangible-Equity was 29.41%. The lowest was 16.42%. And the median was 23.30%.
ROCO:6637's Return-on-Tangible-Equity is ranked better than 72.07% of 111
companies
in the Medical Distribution industry
Industry Median: 8.78
vs ROCO:6637: 17.01
Medical Imaging (ROCO:6637) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Medical Imaging Return-on-Tangible-Equity Related Terms
Medical Imaging Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Medical Imaging's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6637 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Medical Imaging's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Imaging Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medical Imaging's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Medical Imaging's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 9.55% mean?
Medical Imaging (ROCO:6637) has a Return-on-Tangible-Equity of 9.55% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medical Imaging and its competitors. This is 59% below median its historical median of 23.30. Over the past decade, Medical Imaging's Return-on-Tangible-Equity has ranged from 16.42 to 29.41. According to the industry distribution chart, Medical Imaging ranks #31 out of 111 companies in the Medical Distribution industry, placing it in the top 27.9%.
Is Medical Imaging's Return-on-Tangible-Equity too high?
Medical Imaging's current Return-on-Tangible-Equity of 9.55% is 59% below median its 10-year median of 23.30. Over the past 10 years, this metric has ranged from a low of 16.42 to a high of 29.41. The Medical Distribution industry median Return-on-Tangible-Equity is 8.78. Medical Imaging's value of 9.55% is 8.8% above this industry median. Based on the distribution chart, Medical Imaging ranks #31 out of 111 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medical Imaging has a GF Score™ of 86/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medical Imaging's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medical Imaging ranks #31 out of 111 companies for Return-on-Tangible-Equity. This puts Medical Imaging in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.78. Medical Imaging's value of 9.55% is 8.8% above this benchmark. Historically, Medical Imaging's own Return-on-Tangible-Equity has ranged from 16.42 to 29.41 over the past decade. While the company's 10-year median is 23.30 vs. the industry median of 8.78, Medical Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.78, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Imaging's current Return-on-Tangible-Equity of 9.55% is 8.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medical Imaging and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Imaging's current Return-on-Tangible-Equity is 9.55%, which is 59% below median its own 10-year median of 23.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Imaging stock overvalued right now?
Based on GuruFocus' analysis, Medical Imaging (ROCO:6637) is currently considered Possible Value Trap. The stock's GF Value™ is NT$129.62, compared to a current price of NT$62.00 — trading 52.2% below its estimated fair value. The current Return-on-Tangible-Equity is 9.55%, which is 59% below median its 10-year median of 23.30 and 8.8% above the Medical Distribution industry median of 8.78. Medical Imaging's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Medical Imaging (ROCO:6637), the current Return-on-Tangible-Equity is 9.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Imaging (ROCO:6637) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Imaging stock appears to be undervalued.
The current stock price of NT$62.00 is trading 52.2% below its estimated GF Value™ of NT$129.62.
GuruFocus considers Medical Imaging to be Possible Value Trap.
Key valuation signals for ROCO:6637:
Return-on-Tangible-Equity: 9.55% (59% below median its 10-year median of 23.30)
GF Value™: NT$129.62 vs. price of NT$62.00 (52.2% below fair value)
Industry Position: 8.8% above the Medical Distribution median (#31 of 111)
No single metric tells the full story. See the ROCO:6637 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Imaging Corp is a Taiwan based medical equipment company. It is engaged in medical equipment distribution, hospital equipment rental, and equipment maintenance.
86GF Score
Get the complete analysis for ROCO:6637
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6637 has been successfully added to your 
